POST SUMMARY: One of the reasons that pharma is allocating money to digital channels to reach HCP’s is that access by sales reps continues to decline from 77.1% in 2009 to 68.1% in 2014.
POST SUMMARY: One of the reasons that pharma is allocating money to digital channels to reach HCP’s is that access by sales reps continues to decline from 77.1% in 2009 to 68.1% in 2014.